OVERVIEW

The global In-Vitro diagnostic market size is expected to surpass USD 1,13,986 million by 2026 on account of COVID-19, growing at a CAGR of 4.90 percent over the forecast period. The COVID-19 pandemic turned the spotlight on in-vitro diagnostics, since there's an increasing demand for the IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV2 viral infection among the worldwide population. The outbreak of COVID-19 is predicted to positively impact the market studied, as in-vitro diagnostics involves testing of varied biological samples. this is often expected to assist the diagnosis of infectious diseases, like COVID-19.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global In Vitro Diagnostics Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global In Vitro Diagnostics Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global In Vitro Diagnostics Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global In Vitro Diagnostics Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global In Vitro Diagnostics Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global In Vitro Diagnostics Market ? By Product & Service (Market Size ? & million/billion)
  • 8.1 Reagents & Kits
  • 8.2 Instruments
  • 8.3 Data Management Software
  • 8.4 Services

• 9 Global In Vitro Diagnostics Market - By Technology
  • 9.1 Immunochemistry/Immunoassay
  • 9.2 Hematology
  • 9.3 Coagulation & Hemostasis
  • 9.4 Molecular Diagnostics
  • 9.5 Clinical Chemistry
  • 9.6 Microbiology
  • 9.7 Urinalysis
  • 9.8 Others

• 10 Global In Vitro Diagnostics Market - By Application
  • 10.1 Autoimmune Diseases
  • 10.2 Drug Testing/Pharmacogenomics
  • 10.3 Infectious Diseases
  • 10.4 Cardiology
  • 10.5 Diabetes
  • 10.6 Nephrology
  • 10.7 HIV/AIDS
  • 10.8 Oncology/Cancer
  • 10.9 Others

• 11 Global In Vitro Diagnostics Market - By End-User
  • 11.1 Laboratories
  • 11.2 Point-Of-Care Testing
  • 11.3 Patient Self-Testing
  • 11.4 Hospitals
  • 11.5 Academics
  • 11.6 Others

• 12 Global In Vitro Diagnostics Market ? By Geography (Market Size ? & million/billion)
  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global In Vitro Diagnostics Market ? Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global In Vitro Diagnostics Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Abbott Laboratories, Inc.
  • 14.3 Johnson & Johnson
  • 14.4 Roche Diagnostics
  • 14.5 Danaher Corporation
  • 14.6 Agilent Technologies
  • 14.7 Siemens AG
  • 14.8 Becton, Dickinson and Company
  • 14.9 Biom?rieux Sa
  • 14.10 Thermo Fisher Scientific
  • 14.11 Bio-Rad Laboratories, Inc.
  • 14.12 Company 11 & more

• 15 Global In Vitro Diagnostics Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations